Global immunology market to grow by $65.8b by 2028 | Healthcare Asia Magazine
, APAC
Photo by Pixabay via Pexels

Global immunology market to grow by $65.8b by 2028

It is driven by advancements in organ transplantation and a strong pipeline of immunological agents.

The global immunology market is expected to grow by $65.8b from 2024 to 2028, with a compound annual growth rate (CAGR) of 9.45%, according to Technavio. 

The growth is driven by advancements in organ transplantation and a strong pipeline of immunological agents. However, the rise of biosimilars presents challenges to market growth.

As of October 2021, 51 molecules are in development, with 22 in Phase II trials and four in Phase III. 

The increasing prevalence of infections and cancers is also driving demand for systemic medications, including interleukin-6 inhibitors and DMARDs. 

The report noted that pharmacists are essential in managing drug schedules. Innovative therapies and targeted immunotherapies, such as Rituximab and Adalimumab, are also changing the treatment landscape, especially for cancer and allergies.
 

Join Healthcare Asia Magazine community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!